GeneBio Systems
Recombinant chiken IGF1/IGF‑I/IGF-1 protein (His tag)
Recombinant chiken IGF1/IGF‑I/IGF-1 protein (His tag)
SKU:PDEO100025
Couldn't load pickup availability
Size:100μg
Storage:Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Shipping:This product is provided as lyophilized powder which is shipped with ice packs.
Exp date:12 months
Category ID_II:Recombinant Proteins
Category ID_III:Others
Abbreviation:IGF1;IGF-1
Target Synonym:IGF1;Insulin-like growth factor I
Research Areas:Cancer;Developmental Biology;Neuroscience;signal Transduction;Stem Cells;Metabolism
Conjugation:
Target Species:Chicken
Expression Host:E.coli
Application:
Fusion tag:N-His
UNIProt ID:P18254
Accession:P18254
Background:IGF I, also known as Mechano Growth Factor, somatomedin-C, IGF-I, and IGF1, is a secreted protein that belongs to the insulin family. The insulin family, comprised of insulin, relaxin, insulin-like growth factors I and II ( IGF-I and IGF-II ), and possibly the beta-subunit of 7S nerve growth factor, represents a group of structurally related polypeptides whose biological functions have diverged. The IGFs, or somatomedins, constitute a class of polypeptides that have a key role in pre-adolescent mammalian growth. IGF-I expression is regulated by GH and mediates postnatal growth, while IGF-II appears to be induced by placental lactogen during prenatal development. IGF1 / IGF-I may be a physiological regulator of [1-14C]-2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblasts. IGF1 / IGF-I stimulates glucose transport in rat bone-derived osteoblastic (PyMS) cells and is effective at much lower concentrations than insulin, not only regarding glycogen and DNA synthesis but also about enhancing glucose uptake. Defects in IGF1 / IGF-I are the cause of insulin-like growth factor I deficiency (IGF1 deficiency) which is an autosomal recessive disorder characterized by growth retardation, sensorineural deafness, and mental retardation.
Concentration:
Activity:Not validated for activity
Sequence:Gly 49-Met 153
Purity: > 95% as determined by reducing SDS-PAGE.
Formulation:Lyophilized from sterile PBS, pH 7.4.
Normally 5%-8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Reconstitution:It is recommended that sterile water be added to the vial to prepare a stock solution of 0.5 mg/mL. Concentration is measured by UV-Vis.
Endotoxin:< 10 EU/mg of the protein as determined by the LAL method.
Calculated MW:11.4 kDa
ObservedMW:13 kDa
